Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

GOETZ H KLOECKER

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1306827126
CMS profile
285695
Location
LOUISVILLE, KY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$115,469.97

103 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 103 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

GOETZ H KLOECKER

NPI 1306827126 · CMS profile ID 285695

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

LOUISVILLE, KY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 103 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1306827126?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
GOETZ H KLOECKER, NPI 1306827126, CMS profile ID 285695. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 103 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1306827126?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). GOETZ H KLOECKER, NPI 1306827126, CMS profile ID 285695. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 103 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1306827126?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
GOETZ H KLOECKER, NPI 1306827126, CMS profile ID 285695, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 103 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1306827126?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

103 matching records · $115,469.97 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 103 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 103.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
JAZZ PHARMACEUTICALS INC. $30.1309/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951329771 CMS
JAZZ PHARMACEUTICALS INC. $115.5809/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951365629 CMS
EMD Serono, Inc. $107.7809/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941564895 CMS
EMD Serono, Inc. $4,830.0009/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941564953 CMS
GENZYME CORPORATION $127.1909/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938829475 CMS
E.R. Squibb & Sons, L.L.C. $95.7109/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745363 CMS
E.R. Squibb & Sons, L.L.C. $16.3009/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745351 CMS
BeiGene USA, Inc. $73.5809/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940798317 CMS
EMD Serono, Inc. $307.5509/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941559883 CMS
EMD Serono, Inc. $107.7309/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941559887 CMS
EMD Serono, Inc. $617.9309/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941559891 CMS
CTI BioPharma Corp. $19.2508/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 933543965 CMS
E.R. Squibb & Sons, L.L.C. $12.4108/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745349 CMS
Novartis Pharmaceuticals Corporation $81.8808/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893845233 CMS
E.R. Squibb & Sons, L.L.C. $123.1708/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745347 CMS
Amgen Inc. $433.0008/05/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051255 CMS
Ipsen Biopharmaceuticals, Inc $121.0108/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893405869 CMS
Sobi, Inc $14.9908/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940364547 CMS
E.R. Squibb & Sons, L.L.C. $4,310.0008/02/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745339 CMS
E.R. Squibb & Sons, L.L.C. $97.2407/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745337 CMS
GENZYME CORPORATION $2,884.0007/20/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938829483 CMS
Amgen Inc. $2,165.0007/06/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051261 CMS
EMD Serono, Inc. $4,830.0007/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941534247 CMS
Amgen Inc. $2,165.0006/22/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051257 CMS
EMD Serono, Inc. $149.6406/22/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941529743 CMS
EMD Serono, Inc. $1,039.5006/22/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941530249 CMS
AstraZeneca Pharmaceuticals LP $450.0006/09/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914832127 CMS
Coherus Biosciences Inc. $121.4406/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956566419 CMS
JAZZ PHARMACEUTICALS INC. $101.2806/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951350275 CMS
EMD Serono, Inc. $2,070.0005/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941520047 CMS
AstraZeneca Pharmaceuticals LP $5,500.0005/23/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915314477 CMS
AstraZeneca Pharmaceuticals LP $121.4105/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915584639 CMS
E.R. Squibb & Sons, L.L.C. $107.4205/16/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745317 CMS
E.R. Squibb & Sons, L.L.C. $300.0005/10/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745405 CMS
GENZYME CORPORATION $114.3205/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938829453 CMS
GENZYME CORPORATION $4,110.0005/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938829455 CMS
GENZYME CORPORATION $728.8405/10/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938829501 CMS
Genentech USA, Inc. $412.5005/02/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950666549 CMS
GENZYME CORPORATION $2,466.0004/26/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 938829451 CMS
Amgen Inc. $2,165.0004/19/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051247 CMS
AstraZeneca Pharmaceuticals LP $250.0004/18/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915506285 CMS
E.R. Squibb & Sons, L.L.C. $300.0004/13/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745401 CMS
E.R. Squibb & Sons, L.L.C. $99.4203/30/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745313 CMS
E.R. Squibb & Sons, L.L.C. $9.3903/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745309 CMS
Genentech USA, Inc. $1,925.0003/12/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950682407 CMS
E.R. Squibb & Sons, L.L.C. $4,310.0003/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932745299 CMS
Amgen Inc. $2,600.0003/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051249 CMS
Amgen Inc. $433.0003/07/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051251 CMS
Amgen Inc. $771.7503/07/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051253 CMS
Amgen Inc. $118.8003/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940051245 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $108,753.54 198
PY2020 $70,557.44 69
PY2021 $50,012.03 44
PY2022 $115,469.97 103
PY2023 $81,365.74 146
PY2024 $66,182.39 198
PY2025 $91,644.05 224

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $357,965.57 7
PY2024 Principal investigator $102,577.11 5
PY2022 Principal investigator $22,206.00 1
PY2021 Principal investigator $29,800.00 1
PY2019 Principal investigator $81,616.98 12

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

7 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Merck Sharp & Dohme LLC $133,908.66 12/31/2025 Non-covered Recipient Entity
The University of Louisville, James Graham Brown Cancer Center
A Randomized, Open label, Phase 3 Study of MK-2870 in Combination with Pembrolizumab Compared to Pembrolizumab Monotherapy in the First-line Treatment of Participants With Metastatic Non-small Cell Lung Cancer with PD-L1 TPS Greater Than or Equal To 50 No dispute reported 06/30/2026 1232922860
Principal investigator 1 Merck Sharp & Dohme LLC $336.63 12/31/2025 Non-covered Recipient Entity
James Graham Brown Cancer Center
A Randomized, Double-Blind, Phase III Study of Carboplatin-Paclitaxel,Nab-Paclitaxel Chemotherapy with or without Pembrolizumab MK-3475 in First Line Metastatic Squamous Non-small Cell Lung Cancer Subjects KEYNOTE-407 No dispute reported 06/30/2026 1232925955
Principal investigator 1 Amgen Inc. $13,911.00 11/22/2025 Non-covered Recipient Entity
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy No dispute reported 06/30/2026 1246650400
Principal investigator 1 Merck Sharp & Dohme LLC $132,841.20 08/31/2025 Non-covered Recipient Entity
The University of Louisville, James Graham Brown Cancer Center
A Phase 3, Randomized, Double-blind, Placebo- and Active-Comparator-Controlled Clinical Study of Adjuvant V940 mRNA-4157 Plus Pembrolizumab Versus Adjuvant Placebo Plus Pembrolizumab in Participants With Resected Stage II, IIIA, IIIB N2 Non-small Cell No dispute reported 06/30/2026 1232932819
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $27,295.50 07/14/2025 Non-covered Recipient Entity
Uofl Health James Graham Brown Cancer Center
A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) No dispute reported 06/30/2026 1235992321
Principal investigator 1 Mirati Therapeutics, Inc. $15,211.00 07/11/2025 Non-covered Recipient Entity
University Of Louisville Research Foundation, Inc,
A Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation No dispute reported 06/30/2026 1236530443
Principal investigator 1 Amgen Inc. $34,461.58 02/21/2025 Non-covered Recipient Entity
UNIVERSITY OF LOUISVILLE HEALTH
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of Tarlatamab Therapy in Subjects With Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Who Have Not Progressed Following Concurrent Chemoradiation Therapy No dispute reported 06/30/2026 1246650392